tSCS in Children With Spina Bifida
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-17
SponsorBailey Petersen
About this trial
A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.
Eligibility criteria
Qualifiers
Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
Between the ages of 4 and 17 years of age.
Documented neurogenic bladder dysfunction
Disqualifiers
Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator.
Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months.
Is pregnant. Pregnancy will be assessed via verbal report.
Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation.
Trial design
Treatments tested in this trial
- Transcutaneous stimulator
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Bailey Petersen
Lead sponsor
University of Pittsburgh
Sponsor institution
Source ClinicalTrials.gov